Page last updated: 2024-08-22

mannose and amphotericin b

mannose has been researched along with amphotericin b in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's2 (16.67)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Barwicz, J; Gruda, I; Rocheleau, H; Saint-Germain, G; Thérien, HM1
Beloborodova, NV; Boĭko, NB; Demina, AM; Kurchavov, VA; Pozdorovkina, VV; Rogatina, EA1
Ali, N; Veerareddy, PR; Vobalaboina, V1
Dube, A; Dubey, V; Jain, NK; Mishra, D; Mishra, PK; Nahar, M1
Jain, NK; Nahar, M1
Gulbake, A; Jain, A; Jain, SK; Khare, P; Rathore, A; Shilpi, S1
Mishra, PR; Singodia, D; Verma, A; Verma, RK1
Jain, NK; Mehra, NK; Pruthi, J1
Barros, D; Cordeiro-da-Silva, A; Costa Lima, SA1
Akhtar, S; Edagwa, BJ; Gendelman, HE; McMillan, J; Qureshi, NA; Raza, A; Shahnaz, G; Yasinzai, M1
Akhtar, S; Gendelman, HE; Nadhman, A; Rehman, AU; Saljoughian, N; Sarwar, HS; Satoskar, AR; Shahnaz, G; Sohail, MF; Yasinzai, M1
Ballesteros, MP; Bolás, F; Chauzy, A; de Pablo, E; Dea-Ayuela, MA; Fernández-García, R; Healy, AM; Kumar, D; Marchand, S; O'Connell, P; Serrano, DR; Tewes, F; Torrado, JJ1

Other Studies

12 other study(ies) available for mannose and amphotericin b

ArticleYear
Modulation of amphotericin B activity by association with mannose ester.
    Immunopharmacology and immunotoxicology, 1994, Volume: 16, Issue:3

    Topics: Amphotericin B; Animals; Cell Division; Cell Line; Detergents; Hydrogen Peroxide; Macrophages, Peritoneal; Mannose; Mice; Mice, Inbred BALB C; Spectrophotometry

1994
[Gas chromatography in express diagnosis of candidiasis and monitoring of antifungal therapy efficacy by D-arabinitol and mannose levels in pediatric patients].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1998, Volume: 43, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Chromatography, Gas; Female; Fluconazole; Humans; Infant; Male; Mannose; Sugar Alcohols

1998
Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres.
    Journal of drug targeting, 2009, Volume: 17, Issue:2

    Topics: Amphotericin B; Animals; Brain; Drug Carriers; Kidney; Leishmania donovani; Leishmaniasis; Liver; Mannose; Mice; Mice, Inbred BALB C; Nanospheres; Spleen; Tissue Distribution; Trypanocidal Agents

2009
In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis.
    Journal of drug targeting, 2010, Volume: 18, Issue:2

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Drug Carriers; Gelatin; Leishmaniasis, Visceral; Macrophages; Mannose; Nanoparticles

2010
Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles.
    Pharmaceutical research, 2009, Volume: 26, Issue:12

    Topics: Amphotericin B; Antiprotozoal Agents; Drug Delivery Systems; Flow Cytometry; Humans; Lactic Acid; Leishmania donovani; Macrophages; Mannose; Microscopy, Electron, Transmission; Molecular Structure; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Surface Properties

2009
Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis.
    Journal of liposome research, 2011, Volume: 21, Issue:4

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cations; Cricetinae; Female; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Macrophages; Male; Mannose; Mesocricetus; Molecular Structure

2011
Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery.
    Nanomedicine : nanotechnology, biology, and medicine, 2012, Volume: 8, Issue:4

    Topics: Acetylglucosamine; Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Lectins, C-Type; Leishmaniasis; Liposomes; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Particle Size; Rats; Rats, Wistar; Receptors, Cell Surface

2012
Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes.
    Journal of drug targeting, 2012, Volume: 20, Issue:7

    Topics: Amphotericin B; Animals; Drug Delivery Systems; Female; Hemolysis; Hydrogen-Ion Concentration; Kidney; Macrophages; Male; Mannose; Nanotubes, Carbon; Particle Size; Rats; Rats, Sprague-Dawley; Tissue Distribution

2012
Surface functionalization of polymeric nanospheres modulates macrophage activation: relevance in leishmaniasis therapy.
    Nanomedicine (London, England), 2015, Volume: 10, Issue:3

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cells, Cultured; Cytokines; Drug Carriers; Lactic Acid; Leishmaniasis; Macrophage Activation; Macrophages; Male; Mannans; Mannose; Mice; Mice, Inbred BALB C; Nanospheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers

2015
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
    Nanomedicine (London, England), 2017, Volume: 12, Issue:2

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Nanoparticles

2017
Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup1

    Topics: Adhesiveness; Administration, Oral; Amphotericin B; Animals; Biological Availability; Cell Membrane; Chitosan; Drug Carriers; Drug Compounding; Immunomodulation; Leishmaniasis, Visceral; Mannose; Mice; Nanoparticles; Nitric Oxide; Particle Size; Permeability; Safety; Tissue Distribution

2018
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers.
    International journal of pharmaceutics, 2023, Mar-25, Volume: 635

    Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Dry Powder Inhalers; Humans; Lung; Macrophages, Alveolar; Mannose; Particle Size; Pneumonia; Powders; Respiratory Aerosols and Droplets

2023